Phenytoin I: In vitro–in vivo correlation for 100-mg phenytoin sodium capsules
✍ Scribed by Vinod P. Shah; Vadlamani K. Prasad; Treva Alston; Bernard E. Cabana; Richard P. Gural; Marvin C. Meyer
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 313 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
✦ Synopsis
Compound IV was prepared in the same manner as described for 111, but with piperazinefi. After evaporation of the solvents, the residue crystallized from 1:l diethyl ether-petroleum ether: 2.3 g, 32% yield, mp 120- 122'; NMR (chloroform-d): d 2.65 (s, 16H, CHz), 3.87 (s, 18H, OCHB),
📜 SIMILAR VOLUMES
Communicated by Savio L. C. Woo Mutations at the phenylalanine hydroxylase (PAH) locus are the major cause of hyperphenylalaninemia. We have previously described four mutations (MlV, IVS12nt1, R408W, and S349P) at the PAH locus in French Canadians with ancestry in eastern Quebec. Here we report (1)
A new generation drug delivery system, named the Microsealed Drug Delivery (MDD) system, was developed. Subcutaneous implantation of MDD's in rats for up to 129 days resulted in a constant release profile of desoxycorticosterone acetate. Three formulations were examined. An excellent i n uitro-in ui